Gabexate Mesilate


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 34.5%
Acute Myeloid Leukaemia 11.5%
Fluid Replacement 9.6%
Agranulocytosis 5.7%
Disseminated Intravascular Coagulation 3.8%
Liver Disorder 3.8%
Alcoholic Pancreatitis 3.4%
Pancreatitis Chronic 3.4%
Pancreatitis Relapsing 3.4%
Antipyresis 1.9%
Diabetes Mellitus 1.9%
Diagnostic Procedure 1.9%
Electrolyte Substitution Therapy 1.9%
Hepatitis B 1.9%
Hypersensitivity 1.9%
Medical Diet 1.9%
Nausea 1.9%
Tumour Excision 1.9%
Venipuncture 1.9%
Drug Use For Unknown Indication 1.5%
Eosinophil Count Increased 30.0%
White Blood Cell Count Decreased 25.0%
Pancreatitis Acute 20.0%
Disseminated Intravascular Coagulation 10.0%
Pyrexia 5.0%
Rash 5.0%
Shock 5.0%
Concomitant
Drug Use For Unknown Indication 18.6%
Product Used For Unknown Indication 13.8%
Prophylaxis 12.9%
Acute Myeloid Leukaemia 6.9%
Infection Prophylaxis 6.5%
Acute Promyelocytic Leukaemia 5.5%
Disseminated Intravascular Coagulation 5.5%
Aplastic Anaemia 5.4%
Crohn's Disease 3.6%
Bone Marrow Conditioning Regimen 2.9%
Prophylaxis Against Graft Versus Host Disease 2.5%
Fluid Replacement 2.4%
Pain 2.2%
Pneumonia 2.1%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Antifungal Prophylaxis 1.8%
Antiviral Prophylaxis 1.4%
Constipation 1.4%
Gastric Ulcer 1.4%
Liver Abscess 1.4%
Systemic Inflammatory Response Syndrome 12.6%
White Blood Cell Count Decreased 12.6%
Renal Impairment 8.1%
Sepsis 8.1%
Hepatic Function Abnormal 5.4%
Speech Disorder 5.4%
Thrombocytopenia 5.4%
Multi-organ Failure 4.5%
Viral Dna Test Positive 4.5%
Lactic Acidosis 3.6%
Protein Total Decreased 3.6%
Shock 3.6%
Weight Increased 3.6%
White Blood Cell Count Increased 3.6%
Febrile Neutropenia 2.7%
Pancreatitis 2.7%
Pseudomonal Sepsis 2.7%
Pyrexia 2.7%
Renal Failure 2.7%
Abortion Induced 1.8%

Drug Data